Data Dictionary: Belgian Cancer Registry: Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
Source: | Source: | ||
{| class="wikitable" | |||
|+ Patient Information and Treatment Data | |||
|- | |||
! Aspect !! Description | |||
|- | |||
| Unique patient identification including demographic parameters || (i.e., date of birth, gender, zip code) and unique identification of the care program and hospital | |||
|- | |||
| Diagnosis according to international classification || including date of incidence | |||
|- | |||
| Tumor stage (cTNM) || | |||
|- | |||
| Conclusion of the pathological report || (including pTNM) | |||
|- | |||
| Treatment with reference to guidelines or justification of deviation || | |||
|- | |||
| Follow-up plan || | |||
|- | |||
| Side effects || | |||
|- | |||
| Disease-free survival and survival || (i.e., treatment outcome) | |||
|- | |||
| Date of death || | |||
|} | |||
Revision as of 14:07, 30 April 2024
Go back to Belgium page
Source:
| Aspect | Description |
|---|---|
| Unique patient identification including demographic parameters | (i.e., date of birth, gender, zip code) and unique identification of the care program and hospital |
| Diagnosis according to international classification | including date of incidence |
| Tumor stage (cTNM) | |
| Conclusion of the pathological report | (including pTNM) |
| Treatment with reference to guidelines or justification of deviation | |
| Follow-up plan | |
| Side effects | |
| Disease-free survival and survival | (i.e., treatment outcome) |
| Date of death |
Source: Click here to learn more.
| Aspects of Participation and Screening Test Usage |
| Aspects of participation |
| Use of the screening test in the target group |
| Results obtained and their use (including cancer detection rate, sensitivity, and specificity) |
| Cyto-histopathology register |
| Results of further follow-up |